Kenneth D. Herbst

478 total citations
14 papers, 358 citations indexed

About

Kenneth D. Herbst is a scholar working on Molecular Biology, Rheumatology and Hematology. According to data from OpenAlex, Kenneth D. Herbst has authored 14 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Rheumatology and 3 papers in Hematology. Recurrent topics in Kenneth D. Herbst's work include Chronic Myeloid Leukemia Treatments (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Medical Imaging Techniques and Applications (1 paper). Kenneth D. Herbst is often cited by papers focused on Chronic Myeloid Leukemia Treatments (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Medical Imaging Techniques and Applications (1 paper). Kenneth D. Herbst collaborates with scholars based in United States, Germany and Singapore. Kenneth D. Herbst's co-authors include Maike de Wit, D. Bumann, Dieter K. Hossfeld, W. Beyer, M. Clausen, Michael P. Corder, Glen R. Justice, E Frei, Gerry R. Boss and Stephen B. Howell and has published in prestigious journals such as Annals of Internal Medicine, Cancer and The American Journal of Sports Medicine.

In The Last Decade

Kenneth D. Herbst

13 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kenneth D. Herbst United States	8	148	105	87	81	80	14	358
Paraskevi Roussou Greece	13	120 0.8×	40 0.4×	152 1.7×	75 0.9×	35 0.4×	21	528
Jordan Hankins United States	11	282 1.9×	260 2.5×	43 0.5×	85 1.0×	69 0.9×	16	480
Monika Długosz‐Danecka Poland	13	297 2.0×	66 0.6×	145 1.7×	58 0.7×	81 1.0×	44	485
Fazıl Aydin Türkiye	11	54 0.4×	37 0.4×	27 0.3×	88 1.1×	29 0.4×	32	345
Vittorio Ruggero Zilioli Italy	10	156 1.1×	19 0.2×	112 1.3×	23 0.3×	61 0.8×	33	329
Holly J. Meany United States	14	55 0.4×	43 0.4×	31 0.4×	89 1.1×	185 2.3×	30	423
C Weiler United States	6	46 0.3×	90 0.9×	34 0.4×	64 0.8×	11 0.1×	8	426
Florence Broussais‐Guillaumot France	9	228 1.5×	16 0.2×	95 1.1×	24 0.3×	57 0.7×	14	305
Başak Oyan Türkiye	12	45 0.3×	35 0.3×	26 0.3×	92 1.1×	25 0.3×	39	348
Tove Wästerlid Sweden	9	176 1.2×	14 0.1×	67 0.8×	31 0.4×	66 0.8×	28	280

Countries citing papers authored by Kenneth D. Herbst

Since Specialization

Citations

This map shows the geographic impact of Kenneth D. Herbst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth D. Herbst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth D. Herbst more than expected).

Fields of papers citing papers by Kenneth D. Herbst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth D. Herbst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth D. Herbst. The network helps show where Kenneth D. Herbst may publish in the future.

Co-authorship network of co-authors of Kenneth D. Herbst

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth D. Herbst. A scholar is included among the top collaborators of Kenneth D. Herbst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth D. Herbst. Kenneth D. Herbst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Papoiu, Alexandru D.P., et al.. (2015). TriCalm® hydrogel is significantly superior to 2% diphenhydramine and 1% hydrocortisone in reducing the peak intensity, duration, and overall magnitude of cowhage-induced itch. Clinical Cosmetic and Investigational Dermatology. 8. 223–223. 7 indexed citations

Eskander, Ramez N., et al.. (2011). Chronic myelocytic leukemia in pregnancy: A case report describing successful treatment using multimodal therapy. Journal of obstetrics and gynaecology research. 37(11). 1731–1733. 11 indexed citations

Zhang, Jing, Di Xiang, Shunying Zhu, et al.. (2008). Interleukin 1 receptor antagonist inhibits normal hematopoiesis and reduces lethality and bone marrow toxicity of 5-fluouracil in mouse. Biomedicine & Pharmacotherapy. 63(7). 501–508. 24 indexed citations

Jamali, Amir A., et al.. (2006). Acute Compartment Syndrome Due to Ruptured Baker Cyst after Nonsurgical Management of an Anterior Cruciate Ligament Tear. The American Journal of Sports Medicine. 34(4). 657–660. 6 indexed citations

Takabe, Kazuaki, et al.. (2004). Successful perioperative management of factor X deficiency associated with primary amyloidosis. Journal of Gastrointestinal Surgery. 8(3). 358–362. 26 indexed citations

Mross, K., Nicolaus Kröger, Kenneth D. Herbst, Guenther Gastl, & D Hossfeld. (1999). Alteration in Epirubicin Pharmacokinetics and Metabolism by Dexverapamil: Results from a Phase II Study in Patients with Metastatic Breast Cancer. Oncology Research and Treatment. 22(1). 35–40. 5 indexed citations

Wit, Maike de, D. Bumann, W. Beyer, et al.. (1997). Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma. Annals of Oncology. 8. S57–S60. 135 indexed citations

Mross, K., Andreas Hüttmann, Kenneth D. Herbst, et al.. (1996). Pharmacokinetics and pharmacodynamics of the new podophyllotoxin derivative NK 611 A study by the AIO groups PHASE-I and APOH. Cancer Chemotherapy and Pharmacology. 38(3). 217–224. 16 indexed citations

Corder, Michael P., Hamed H. Tewfik, Gerald H. Clamon, et al.. (1984). Radiotherapy plus razoxane for advanced limited extent carcinoma of the lung. Cancer. 53(9). 1852–1856. 4 indexed citations

10.

Herbst, Kenneth D., et al.. (1981). Syndrome of an Acquired Inhibitor of Factor VIII Responsive to Cyclophosphamide and Prednisone. Annals of Internal Medicine. 95(5). 575–578. 30 indexed citations

11.

Howell, Stephen B., Kenneth D. Herbst, Gerry R. Boss, & E Frei. (1980). Thymidine requirements for the rescue of patients treated with high-dose methotrexate.. PubMed. 40(6). 1824–9. 30 indexed citations

12.

Herbst, Kenneth D., Michael P. Corder, & Eugene Morita. (1978). Hepatic Scan Defects Following Radiotherapy for Lymphoma. Clinical Nuclear Medicine. 3(8). 331–333. 1 indexed citations

13.

Herbst, Kenneth D., Michael P. Corder, & Glen R. Justice. (1976). Successful therapy with methotrexate of a multicentric mixed lymphoma of the central nervous system. Cancer. 38(4). 1476–1478. 59 indexed citations

14.

Herbst, Kenneth D.. (1975). Chronic Thrombocytopenia Following Gold Therapy. Archives of Internal Medicine. 135(12). 1622–1622. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact